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Abstract 
Background: Systemic inflammation, neurocognitive impairments, and morphologic brain changes are associ‑
ated with obstructive sleep apnea (OSA). Understanding their longitudinal evolution and interactions after surgical 
treatment provides clues to the pathogenesis of cognitive impairment and its reversibility. In the present study, we 
investigate clinical disease severity, systemic inflammation, cognitive deficits, and corresponding gray matter volume 
(GMV) changes in OSA, and the modifications following surgery.
Methods: Twenty‑one patients with OSA (apnea‑hypopnea index, AHI > 5) and 15 healthy volunteers (AHI < 5) 
underwent serial evaluation, including polysomnography, flow cytometry for leukocyte apoptosis categorization, cog‑
nitive function evaluation, and high‑resolution brain scan. Disease severity, leukocyte apoptosis, cognitive function, 
and imaging data were collected to assess therapeutic efficacy 3 months after surgery.
Results: Pre‑operatively, patients presented with worse cognitive function, worse polysomnography scores, and 
higher early leukocyte apoptosis associated with increased insular GMV. There was reduced GMV in the anterior 
cingulate gyrus before and after surgery in the cases compared to that in controls, suggesting an irreversible struc‑
tural deficit. Post‑operatively, there were significant improvements in different cognitive domains, including attention, 
executive and visuospatial function, and depression, and in early leukocyte apoptosis. There was also a significant 
decrease in GMVs after treatment, suggesting recovery from vasogenic edema in the precuneus, insula, and cerebel‑
lum. Improvement in early leukocyte apoptosis post‑surgery predicted better recovery of precuneus GMV.
Conclusions: In OSA, increased disease severity and systemic inflammation can alter GMV in vulnerable regions. 
Surgical treatment may improve disease severity and systemic inflammation, with subsequent recovery in brain struc‑
tures and functions.
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Background
Obstructive sleep apnea (OSA) is characterized by 
repetitive episodes of apnea or hypopnea during sleep. 
Sleep fragmentation and intermittent hypoxia in OSA 
can trigger elevated oxidative stress and subsequent 
inflammation [1]. Several imaging studies have demon-
strated structural and functional changes in the brains of 
patients with OSA, with corresponding neuropsychologi-
cal impairments [2]. Treatments, such as continuous pos-
itive airway pressure (CPAP), can significantly improve 
memory, attention, and executive function that paral-
lels correction of the structural deficits. These data can 
shed light for treatment approaches for OSA and serve as 
motivators for treatment adherence.
The role of peripheral blood inflammatory mark-
ers related to OSA has not yet been systematically 
investigated. Several systemic inflammatory markers 
are involved in endothelial damage that occurs during 
repetitive hypoxia/re-oxygenation injury [3]. The inter-
face between the vascular endothelium and host inflam-
matory response may also be related to the activation 
of resident microglia and peripheral blood leukocytes 
[4], as well as the expression of inflammatory cytokines 
and adhesion molecules [5]. However, the role of these 
inflammatory markers in the pathogenesis of OSA, espe-
cially in its relationship with structural brain alterations 
and cognitive function, as well as the effects of different 
treatments on these markers, remains unclear.
Previous studies have demonstrated that direct oxida-
tive damage associated with sleep deprivation occurs 
across many brain regions [6], and chronic intermittent 
hypoxia can increase brain cortical neuronal cell death 
[7]. Structural evaluation, such as voxel-based mor-
phometry (VBM), is an assumption-free, objective, and 
operator-independent method that applies voxel-wise 
comparisons throughout the brain to detect differences 
in gray matter volume (GMV). Extensive morphologi-
cal alterations in several brain areas in patient with OSA 
had previously been shown by VBM [8]. However, the 
reported structural changes in OSA have been highly 
variable due to different VBM pre-processing pipelines 
and statistical threshold settings used in studies. The 
therapeutic effect of CPAP on structural brain alterations 
is still not conclusive [9–11]. CPAP compliance varies 
from 28 to 80 % [12, 13] and there is a consensus that a 
certain number of OSA patients cannot or will not use 
CPAP. Surgery for OSA is not a substitute for CPAP, but 
a salvage procedure for those who have failed CPAP and 
other conservative therapies. No research to date has 
focused on the effects of surgery in OSA using the rela-
tively optimized longitudinal VBM method.
Serial evaluation before and after surgical treatment, 
and comparison with data from healthy controls, may 
elucidate the underlying morphologic, inflammatory, 
cognitive, and clinical performance changes in OSA 
patients and is essential to improving therapeutic strat-
egies. This study aimed to determine (i) if OSA patients 
demonstrate alteration of GMV after surgical treatment, 
(ii) if changes in GMV are affected by the baseline or 
changes of systemic inflammation and their relationship 
to disease severity after surgery; and (iii) if there is any 
correlation between GMV and cognitive performance 
before and after treatment.
Methods
Participants
This prospective study targeted patients with OSA 
[apnea-hypopnea index (AHI) ≥ 5] evaluated for surgical 
treatment. Twenty-one patients (18 men and 3 women; 
mean age, 40.14 ± 10.80 years; body mass index [BMI], 
26.24 ±  3.40  kg/m2; AHI, 38.77 ±  19.91 events/hr) and 
15 healthy volunteers (AHI < 5) (11 men and 4 women; 
mean age, 39.80 ± 9.53 years; BMI, 23.97 ± 2.50 kg/m2, 
AHI, 2.43 ± 1.61 events/hr) were recruited. The Hospital 
Ethics Committee approved the study and all of the par-
ticipants provided written informed consent.
All of the control subjects and OSA patients, who 
had failed CPAP and other conservative therapies, were 
enrolled through the sleep center after presenting with 
snoring. All participants underwent similar evaluations, 
including clinical characteristics, overnight polysomnog-
raphy (PSG), blood samples for assessment of leukocyte 
apoptosis, neuropsychological tests (NP), and magnetic 
resonance imaging (MRI) for brain structure calculation. 
The last three evaluations were done on the same day and 
within 2 weeks of PSG.
Overnight PSG was assessed according to a previous 
report [14]. All-night comprehensive diagnostic sleep 
studies were performed at the hospital’s sleep center. 
The severity of sleep-disordered breathing was classified 
according to the number of apneas and hypopneas dur-
ing sleep, and was classified as normal for AHI 0–5, mild 
for AHI 5–15, moderate for AHI 15–30, and severe for 
AHI > 30 [15]. Central respiratory events were excluded 
from the severity classification. All PSGs were scored and 
read by a board-certified physician blinded to the study. 
Patients were excluded if they had a history of major 
mental disorder, brain injury or illness, diabetes mellitus, 
cerebrovascular disease, major cardiovascular disorder 
(e.g., stroke, heart failure, myocardial infarction), or cen-
tral/peripheral disorders known to affect the autonomic 
nervous systems.
Concepts of surgical treatment for OSA are based on 
reducing the volume of redundant tissues, stiffening the 
flaccid soft palate, and suspending the collapsed tongue 
base to maintain airway patency in order to improve 
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symptoms and reduce the sequelae of OSA. The efficacy 
and safety of multi-level surgery has been previously 
demonstrated [16]. All of the surgical procedures were 
performed by the co-corresponding author (H-C Lin) 
under general anesthesia, with orotracheal intubation. 
The techniques used were determined at the discretion of 
the treating sleep surgeon based on the severity of OSA 
by PSG, and upper airway abnormalities were examined 
by flexible fibroscopy. The surgical techniques were as 
previously described [17–19].
Assessment of leukocyte apoptosis
Leukocyte apoptosis, and its subtypes, were identified 
according to a previous study [20] with APO 2.7-phyco-
erythrin (PE), early apoptosis, and late apoptosis. Positive 
APO 2.7-PE indicated apoptotic cells. Further analysis 
of early and late apoptosis was conducted by annexin 
V-FITC and 7-aminoactinomycin D (7-AAD). Late apop-
totic cells demonstrated disruption of the cell membrane 
integrity while early apoptotic cells demonstrated early 
and reversible apoptotic changes. Results were expressed 
as percentages of specific fluorescence-positive cells.
Neuropsychological tests
The NP battery of tests focused on attention, execu-
tion function, speech and language, and mnemonic and 
visuoconstruction abilities. Different domain evaluations 
were measured as in previous studies [21, 22] with sub-
tests from the Cognitive Ability Screening Instrument 
(CASI) [23] and the Wechsler Adult Intelligence Scale 
(WAIS-III) [24]. The Beck Depression Inventory II (BDI), 
was used to evaluate severity of depression [25].
MRI image acquisition
All cross-sectional and longitudinal volumetric structural 
MRI was performed on identical 3-Tesla GE Signa whole-
body MRI systems (General Electric Healthcare, Mil-
waukee, WI, USA) equipped with an eight-channel head 
coil at the Kaohsiung Chang Gung Memorial Hospital in 
Taiwan. A T1-weighted three dimensional fluid-atten-
uated inversion-recovery fast spoiled gradient-recalled 
echo pulse sequence was used with following imaging 
parameters for each participant and time-point: TR/TE/
TI  =  9.5/3.9/450  ms; flip angle, 15°; NEX  =  1; matrix 
size = 512 × 512; voxel size = 0.47 × 0.47 × 1.3 mm3; 
and 110 axial slices.
An experienced neuroradiologist, blinded to the par-
ticipants’ status, visually examined all of the MR scans. 
None of the participants in the study were excluded.
Imaging data analysis
Cross-sectional VBM processing To identify regional 
GMV differences between patients with OSA, before and 
after surgical treatment, and the healthy control group, 
structural T1-weighted images were processed using sta-
tistical parametric mapping (SPM8; http://www.fil.ion.
ucl.ac.uk/spm; Wellcome Institute of Neurology, Univer-
sity College London, UK) and the VBM8 toolbox (http://
dbm.neuro.uni-jena.de) with default settings as described 
in the manual. The procedure for the cross-sectional 
VBM pipeline followed that of previous cross-sectional 
based VBM studies from our group [26, 27] (additional 
details available in the Method of the online “Additional 
file 1”).
Longitudinal VBM processing The default longitu-
dinal batch script in the VBM8 toolbox was used to 
identify longitudinal effects to GMV in patients with 
OSA before and after surgical treatment. In this pipe-
line the modulation step was not used because our 
focus was on relative tissue differences between differ-
ent time-points within the same participant [27]. First, 
follow-up (after surgery) T1-weighted scan was reg-
istered to the baseline scan (before surgery). Second, 
the mean anatomic image was calculated using the 
realigned images and served as a reference image for 
realignment of baseline and follow-up scans for each 
participant. Third, the individual realigned baseline 
and follow-up scans were bias corrected to account 
for field inhomogeneities regarding the correspond-
ing mean anatomical scan. Fourth, the resultant bias-
corrected mean anatomical scan and realigned images 
were segmented into GM, WM, and CSF tissue seg-
ments using the VBM8 segmentation approach. Fifth, 
the DARTEL registration parameters were estimated 
using the GM tissue segments of the bias-corrected 
mean anatomical scan. The resulting registration 
parameters were applied to the corresponding tis-
sue segments of the realigned baseline and follow-up 
anatomical scans. The resulting normalized GM seg-
ments for each time point for each participant were 
smoothed using an 8-mm FWHM Gaussian kernel and 
served as inputs for the subsequent longitudinal statis-
tical model.
Statistical analysis
Analysis of demographic data between groups
All statistical analyses of demographic data, including 
clinical profiles, laboratory data, global tissue volume, 
and NP tests, were performed using the independent t 
test, Pearson’s Chi square test, and analysis of covariance 
(ANCOVA), as appropriate (details of statistical analyses 
are noted in the legend of Table 1). The longitudinal data 
were compared in the patient group, before and after sur-
gical treatment, using a paired t-test. All statistical signif-
icance was set at p < 0.05 (version 12, SPSS Inc., Chicago, 
IL, USA).
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Table 1 Demographic characteristics of OSA patients and control subjects
Data are presented as mean (SD)
Age data was compared by independent t-test; sex data was compared by Pearson’s Chi square test; BMI data was compared by ANCOVA after controlling for age and 
sex; Sugar, HbA1c, hs-CRP, smoking, voxel-based morphometry measurement, polysomnography result and leukocyte apoptosis data were compared by ANCOVA 
after controlling for age, sex, and BMI
AHI apnea-hypopnea index; ANCOVA Analysis of Covariance; BMI, body mass index, CSFV cerebrospinal fluid volume; GMV gray matter volume; HDL high-density 
lipoprotein cholesterol; hs-CRP high sensitivity C-reactive protein; LDL low-density lipoprotein cholesterol; NC normal controls; OSA obstructive sleep apnea; TIV total 
intracranial volume; WMV white matter volume
NC vs. OSAbaseline: Statistical comparison was performed by ANCOVA between controls and OSAbaseline
NC vs. OSAfollow: Statistical comparison was performed by ANCOVA between controls and OSAfollow
OSAbaseline vs. OSAfollow: Statistical comparison was performed by paired t test between OSAbaseline and OSAfollow
* Statistical threshold was set at p < 0.05












Sex (M:F) 11:4 18:3 0.418
Age (years) 39.80 (9.53) 40.14 (10.80) 0.922
BMI (kg/m2) 23.97 (2.50) 26.24 (3.40) 25.83 (3.73) 0.050 0.130 0.033*
HbA1c (%) 5.54 (0.25) 5.80 (0.46) 5.75 (0.54) 0.206 0.338 0.537
Sugar (mg/dl) 92.00 (8.04) 93.43 (12.14) 95.05 (12.40) 0.925 0.546 0.217
hs‑CRP (mg/dl) 0.80 (0.81) 3.22 (4.30) 2.32 (2.62) 0.108 0.069 0.292
Total cholesterol 192.10 (34.93) 191.96 (29.98) 194.57 (32.00) 0.880 0.985 0.599
Triglyceride 120.87 (95.78) 156.13 (107.13) 154.87 (79.05) 0.441 0.343 0.926
HDL 62.67 (14.44) 54.70 (10.57) 53.39 (10.32) 0.085 0.056 0.393
LDL 106.40 (34.41) 122.04 (29.46) 115.04 (39.67) 0.171 0.540 0.318
Smoking (yes/no) (14/1) (18/3) (19/2) 0.728 1.000 1.000
Voxel-based morphometry
GMV (ml) 613.32 (49.33) 620.69 (72.14) 620.86 (72.69) 0.707 0.702 0.953
WMV (ml) 587.49 (59.16) 583.96 (53.91) 582.17 (50.92) 0.851 0.722 0.373
CSFV (ml) 216.52 (25.02) 215.96 (22.39) 216.81 (22.52) 0.943 0.971 0.477
TIV (ml) 1417.33 (113.22) 1420.61 (119.15) 1419.83 (119.06) 0.931 0.947 0.674
Polysomnography (PSG)
AHI 2.43 (1.61) 38.77 (19.91) 25.21 (20.93) 0.000* 0.000* 0.004*
De‑saturation index 0.77 (0.82) 26.59 (19.38) 16.88 (19.23) 0.000* 0.006* 0.009*
Average O2 saturation 97.09 (0.82) 95.59 (1.39) 95.81 (1.79) 0.004* 0.053 0.534
Snoring index 208.96 (240.67) 385.71 (179.17) 323.52 (181.58) 0.059 0.278 0.116
Systolic BP (mmHg) 124.90 (15.86) 135.58 (15.38) 132.07 (11.58) 0.538 0.497 0.323
Diastolic BP (mmHg) 75.53 (9.09) 84.58 (11.00) 82.55 (12.01) 0.082 0.142 0.469
Leukocyte apoptosis (%)
Granulocyte APO 2.7 apoptosis 0.429 (0.219) 0.894 (1.012) 0.831 (0.940) 0.160 0.125 0.830
Monocyte APO 2.7 apoptosis 2.135 (1.410) 3.156 (3.321) 2.570 (2.903) 0.439 0.575 0.585
Lymphocyte APO 2.7 apoptosis 0.481 (0.226) 0.658 (0.444) 0.475 (0.255) 0.283 0.835 0.164
Total leukocyte APO 2.7 apoptosis 0.891 (0.426) 1.442 (1.084) 1.271 (1.004) 0.128 0.236 0.626
Granulocyte late apoptosis 11.726 (6.986) 16.667 (10.032) 14.599 (14.039) 0.107 0.331 0.622
Granulocyte early apoptosis 13.920 (5.615)) 23.117 (11.007) 18.250 (12.008) 0.010* 0.302 0.099
Monocyte late apoptosis 12.593 (7.401) 12.480 (8.384) 14.520 (8.876) 0.936 0.428 0.318
Monocyte early apoptosis 15.263 (5.068) 23.254 (8.033) 16.796 (8.342) 0.002* 0.579 0.007*
Lymphocyte late apoptosis 2.331 (1.090) 2.306 (0.915) 2.577 (1.178) 0.906 0.647 0.601
Lymphocyte early apoptosis 5.410 (1.988) 6.716 (2.505) 6.600 (2.624) 0.147 0.210 0.981
Total leukocyte late apoptosis 6.875 (2.588) 7.541 (3.170) 7.972 (4.126) 0.407 0.174 0.744
Total leukocyte early apoptosis 9.203 (1.987) 13.535 (3.713) 10.599 (4.431) 0.000* 0.286 0.021*
Page 5 of 11Lin et al. J Transl Med  (2016) 14:139 
Group comparisons of GMV
Cross-sectional (patient with OSA before/after sur-
gical treatment vs. healthy control) and longitudinal 
(patient with OSA before and after surgical treatment) 
voxel-wise GMV differences were examined using 
ANCOVA (with age, sex, and BMI as covariates) and 
paired t-test with SPM8, respectively. To prevent pos-
sible partial volume effects around the border between 
different tissue segments, voxels with an absolute 
GM probability <0.2 were excluded in the statistical 
analysis.
Whole-brain statistical inferences were considered sig-
nificant at family-wise error (FWE) corrected p  <  0.05 
using the cluster-extend threshold approach with 
3dClusterSim in AFNI (Analysis of Functional NeuroIm-
ages, http://afni.nimh.nih.gov/afni/). Based on the results 
of the Monte Carlo simulation, a cluster size of at least 
453 voxels and at least 639 voxels were considered statis-
tically significant for the cross-sectional and longitudinal 
designs, respectively [3dClusterSim using the follow-
ing parameters: single voxel p  <  0.01, FWHM =  8  mm 
(cross-sectional)/9 mm (longitudinal) with GM mask and 
10,000 simulations].
Correlation among GMV, clinical profile, leukocyte apoptosis, 
and NP tests
The mean GMV was extracted from the clusters, with 
significant statistical difference from the group com-
parisons, for further correlation analysis. Partial Pearson 
correlation analysis adjusted for age, gender, and BMI 
was performed to correlate GMVs showing significant 
differences in cross-sectional and longitudinal effect 
with clinical severity, leukocyte apoptosis, and NP tests. 
Significance was set at a Bonferroni corrected p  <  0.05, 
accounting for multiple ROI comparisons.
Results
Demographic characteristics of the participants
Based on the demographic characteristics of the 21 
OSA cases and 15 controls (Table 1), there were no sig-
nificant differences in age, sex, or BMI between the OSA 
baseline (OSAbaseline, before surgical treatment) and 
control groups. OSAbaseline had significantly higher AHI 
(p  <  0.001), higher desaturation index (p  <  0.001), and 
lower average O2 saturation (p  =  0.004) during sleep, 
compared with controls. After surgery, the OSA follow-
up group (OSAfollow) still had significantly higher AHI 
(p < 0.001) and desaturation index (p = 0.006) compared 
with controls.
After surgical treatment, OSAfollow had significant 
improvements in BMI (p = 0.033), AHI (p = 0.004), and 
desaturation index (p = 0.009) compared with OSAbaseline.
Group comparisons of leukocyte apoptosis
Percentages of early apoptosis of total leukocytes 
(p  <  0.001), granulocytes (p  =  0.010), and monocytes 
(p = 0.002) were significantly higher in OSAbaseline than in 
the controls (Table 1).
In contrast, there were no significant differences in the 
percentages of any kind of leukocyte apoptosis between 
OSAfollow and controls.
Nonetheless, OSAfollow showed significantly decreased 
percentages of early apoptosis of total leukocytes 
(p =  0.021) and monocytes (p =  0.007) compared with 
OSAbaseline.
Group comparisons of NP tests
OSAbaseline had worse short term memory scores com-
pared with controls (p  =  0.048) (Table  2). OSAfollow 
also had improvements in BDI compared with controls 
(p = 0.048).
OSAfollow showed significant improvements in attention 
(processing speed, p  <  0.001), executive function (digit 
symbol, p =  0.001), visuospatial function (block design, 
p = 0.015), and depression (BDI, p = 0.011).
Group comparisons of gray matter volume (GMV)
Regions of GMV difference between pre- and post-oper-
ative scans of patients and controls, and the longitudinal 
changes before and after surgery in the OSA group are 
presented in Table 3 and Fig. 1.
OSAbaseline showed significantly lower GMV in the left 
anterior cingulate gyrus and higher GMV in the right 
insula compared with controls. OSAfollow showed signifi-
cantly lower GMV in the left anterior cingulate gyrus but 
not significantly higher GMV in the right insula when 
compared with controls.
An exploratory group-wise comparison of the OSA 
group before and after surgical treatment revealed that 
after surgery, patients exhibited decreased GMV in 
the left hippocampus/posterior cingulate gyrus/precu-
neus (Hipp/PCG/Precuneus) and left superior temporal 
gyrus/inferior frontal gyrus/insula (STG/IFG/Insula), 
and increased GMV in the left cerebellum (Fig. 2).
Correlations between extracted regional GMV and all 
assessments
Correlations with clinical profiles
Before surgical treatment, worse PSG parameters 
(including higher AHI and desaturation index, and 
lower average O2 saturation) were associated with higher 
GMV in the right insula (p/r = 0.003/0.516; 0.003/0.508; 
0.001/−0.574). After surgical treatment, there was no 
statistically significant correlation between PSG param-
eters and regional GMV (Table 4).
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Improvements in PSG parameters (follow-baseline) 
revealed no statistically significant correlation with 
regional GMV changes (follow-baseline).
Correlations with leukocyte apoptosis
Before surgical treatment, higher percentages of early 
apoptosis in granulocytes, monocytes, and total leu-
kocytes were associated with higher GMV in the right 
insula (p/r  =  0.017/0.419; 0.041/0.364; 0.022/0.405) 
(Table 4).
Improvements (follow-baseline) in early apoptosis 
of granulocytes and total leukocytes were significantly 
associated with recovery of GMV (follow-baseline) 
in the left Hipp/PCG/Precuneus (p/r  =  0.022/0.521; 
0.012/0.562) (Table  4; Fig.  3). Correlation between 
improvements (follow-baseline) in the early apoptosis of 
monocytes and total leukocytes, and recovery of GMV 
(follow-baseline) in the cerebellum tended to significance 
(p/r = 0.060/−0.438; 0.058/−0.442).
Correlations with NP tests
There was no statistically significant correlation between 
differences in regional GMV and NP tests.
After surgical treatment, OSA patients demonstrated 
improvements in cognitive function. However, there 
was no statistically significant correlation between 




(1) Longitudinal evaluation showed that surgery 
significantly improved AHI score, desaturation 
index, cognitive function, and decreased early 
leukocyte apoptosis.
(2) OSA patients may undergo different types of 
GMV changes before and after surgery.
(3) Before treatment, increased GMV in the insula 
was associated with increased disease sever-
Table 2 Cognitive test results of OSA patients and control subjects
Data are presented as mean (SD)
All data were compared by ANCOVA after controlling for age, sex, and BMI
AHI apnea-hypopnea index; ANCOVA Analysis of Covariance; BDI Beck Depression Inventory; BMI body mass index, CASI Cognitive Ability Screening Instrument; NC 
normal controls; OSA obstructive sleep apnea; WAIS Wechsler Adult Intelligence Scale
NC vs. OSAbaseline: Statistical comparison was performed by ANCOVA between controls and OSAbaseline
NC vs. OSAfollow: Statistical comparison was performed by ANCOVA between controls and OSAfollow
OSAbaseline vs. OSAfollow: Statistical comparison was performed by paired t test between OSAbaseline and OSAfollow
* Statistical threshold was set at p < 0.05





NC vs. OSAbaseline NC vs. OSAfollow OSAbaseline vs. OSAfollow
Attention
 Mental control (CASI) 9.53 (0.99) 9.40 (1.70) 9.50 (1.10) 0.664 0.908 0.776
 Attention (CASI) 7.73 (0.59) 7.65 (0.81) 7.60 (0.68) 0.999 0.631 0.716
 Orientation (CASI) 17.93 (0.26) 17.50 (1.82) 17.85 (0.49) 0.366 0.908 0.427
 Processing speed (WAIS‑III) 105.67 (18.36) 100.55 (9.24) 108.55 (11.81) 0.280 0.757 <0.001*
Executive function
 Digit symbol (WAIS‑III) 10.73 (3.04) 10.15 (1.81) 11.50 (2.50) 0.458 0.563 0.001*
 Abstraction (CASI) 9.73 (2.05) 10.25 (1.41) 10.70 (1.17) 0.645 0.145 0.119
Memory function
 Long‑term memory (CASI) 10.00 (0.00) 10.00 (0.00) 10.00 (0.00) 1.000 1.000 1.000
 Short‑term memory (CASI) 11.01 (1.01) 10.06 (1.56) 10.67 (1.50) 0.048* 0.398 0.175
Speech and language function
 Language (CASI) 9.78 (0.46) 9.95 (0.22) 9.95 (0.22) 0.218 0.320 1.000
 Verbal fluency (CASI) 9.27 (1.03) 8.95 (1.57) 9.30 (1.08) 0.265 0.550 0.330
Visuo‑spatial function
 Picture completion (WAIS‑III) 11.20 (2.04) 11.10 (2.15) 11.55 (2.70) 0.495 0.911 0.206
 Letter number search (WAIS‑
III)
9.53 (3.27) 9.45 (2.09) 9.60 (3.27) 0.791 0.959 0.780
 Block design (WAIS‑III) 11.47 (3.36) 11.10 (2.43) 11.95 (2.91) 0.455 0.846 0.015*
 Drawing (CASI) 9.87 (0.52) 9.95 (0.22) 9.90 (0.31) 0.693 0.901 0.577
CASI total score 94.85 (3.70) 94.01 (4.78) 95.47 (3.39) 0.357 0.809 0.163
BDI 8.47 (7.58) 8.50 (8.16) 4.70 (6.11) 0.675 0.048* 0.011*
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ity and higher early leukocyte apoptosis. After 
treatment, recovery from increased GMV in pre-
treatment, particularly in the Hipp/PCG/Precu-
neus, highly correlated with improved leukocyte 
early apoptosis.
(4) OSA patients demonstrated persistently lower 
GMV in the anterior cingulate gyrus, even after 
surgical treatment.
Peripheral leukocyte apoptosis before and after treatment
Changes in peripheral leukocyte apoptosis in OSA before 
and after surgery may partially explain the consequences 
and possible pathophysiology when patients experience 
repetitive episodes of hypoxia/re-oxygenation during the 
transient cessation of breathing [28]. Altered endothe-
lial function is associated with enhanced release of spe-
cific leukocytes and systemic oxidative stress in OSA 
[29]. Previously, the use of CPAP has also been demon-
strated to improve serum levels of C-reactive protein, 
tumor necrosis factor alpha, and interleukin-6, which 
can be further associated with extensive morbidity [30]. 
Increased early leukocyte apoptosis may be because some 
leukocyte injuries have not yet reached necrotic change 
[31] and provide the possibility of reducing activation 
of cell death receptors and mitochondria-dependent 
apoptotic pathways after aggressive treatment [32]. Like 
CPAP, surgical treatment can also alleviate the increased 
systemic inflammation by decreasing early leukocyte 
apoptosis in patients with OSA.
GMV alterations before and after surgery
Although multiple pathophysiologies support the struc-
tural alterations occurring in OSA, differences in the stud-
ied patient population (sample size and disease severity), 
other co-morbidities, and different analysis procedures 
used with variable statistical criteria selection may lead to 
the differences observed between studies [8]. Structural 
changes in brain regions, including the frontal and pari-
etal cortices, hippocampus, temporal gyrus, insula, cingu-
late gyri, caudate nucleus, and deep cerebellar nuclei, have 
been reported [9, 33, 34], and associated with different 
cognitive deficits [35]. According to previous reports [8], 
and this study, GMV reduction in the anterior cingulate 
gyrus before and after surgical treatment should be a hall-
mark of a patient with OSA. Physiologically, the cingulate 
gyrus, together with the insula, is mainly involved in car-
diovascular control and may be damaged by intermittent 
hypoxia and sleep fragmentation.
Three months following surgery, a significant improve-
ment in early leukocyte apoptosis was strengthened by 
the significant correlation with GMV reduction in the 
precuneus. However, the results here conflict with those 
Table 3 Regions of  GMV difference between  pre- and  post-operative scans of  the patients and  controls, and  pre- 
and post-operative longitudinal changes in the OSA group
Gray matter volume (GMV) differences between groups are described in terms of MNI coordinates, voxel extent, brain side, and corresponding anatomical regions. The 
t-score of the voxel with the strongest group effect in a given cluster is also listed. The statistical criteria of the VBM results were set as a cluster level FWE corrected 
p < 0.05 (using a Monte Carlo simulation to correct the multiple comparison problem)
FWE family wised error; Lt left side; MNI Montreal Neurological Institute; Rt right side;  voxel-based morphometry
MNI atlas coordinates Cluster size Anatomical region Brodmann area t-score
x Y z
Regional GMV decrease in OSAbaseline vs. NC
−4 28 19 456 Left Anterior Cingulate Gyrus 24 3.41
Regional GMV increase in OSAbaseline vs. NC
40 −7 −6 612 Right Insula 13 2.99
Regional GMV decrease in OSAfollow vs. NC
−4 28 19 663 Left Anterior Cingulate Gyrus 24 3.65
Regional GMV decrease in OSAfollow vs. OSAbaseline
−24 −37 4 1047 Left Hippocampus (Hipp) 30 5.23
−7 −52 28 Left Posterior Cingulate Gyrus (PCG) 31 3.63
−24 −51 17 Left Precuneus 30 3.55
−49 4 −1 1566 Left Superior Temporal Gyrus (STG) 22 4.48
−42 29 −2 Left Inferior Frontal Gyrus (IFG) 47 3.86
−27 25 −3 Left Insula 13 3.61
Regional GMV increase in OSAfollow vs. OSAbaseline
−15 −81 −27 1254 Left Cerebellum – 4.18
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reported in other related VBM studies in patients with 
OSA. O’Donoghue et  al. showed no significant struc-
tural difference in patients treated with CPAP between 
pre-treatment severe OSA (mean AHI, 71.7 ±  7.0) and 
control subjects, and no changes following therapy 
[36]. Huynh et  al. also reported no differences in GMV 
between patients with moderate-to-severe OSA and 
healthy controls, and no difference between CPAP and 
Fig. 1 Regional gray matter volume differences between OSAbaseline, OSAfollow, and healthy control groups (corrected p < 0.05). Lt, left; Rt, right. For 
visualization, statistical parametric maps were superimposed on the participants’ mean T1 anatomical template for localization of significant gray 
matter volume changes
Fig. 2 Regional gray matter volume differences between OSAbaseline and OSAfollow groups. Hot color map, OSAbaseline > OSAfollow; cold color map, 
OSAfollow > OSAbaseline (Corrected p < 0.05)
Page 9 of 11Lin et al. J Transl Med  (2016) 14:139 
sham CPAP treatment [10]. However, Canessa et  al. [9] 
reported a positive effect of CPAP treatment for severe 
OSA (mean AHI, 55.8 ± 19.1). After treatment, improve-
ments in memory, attention, and executive-functioning 
paralleled GMV increases in hippocampal and frontal 
structures.
The present study enrolled OSA patients rang-
ing from mild to severe disease severity (AHI, 
38.77  ±  19.91; range, 13–75) and found longitudinal 
changes in GMV after surgery. This is partially con-
sistent with Canessa’s observations. The difference in 
results may be explained by the different characteris-
tics of the subject groups, different outcome measures 
and statistical criteria of imaging analyses (tissue vol-
ume vs. tissue concentration, uncorrected vs. corrected 
p-value), and different treatment effects between sur-
gery and CPAP.
Possible pathophysiology of GMV alterations
The mechanism of increased GMV before treatment and 
reduction after treatment can be explained by short-term 
or reversible cerebral vasogenic edema, a phenomenon 
also found in other hypoxic conditions such as high alti-
tude cerebral edema and acute mountain sickness [37, 
38]. An increased permeability of the blood brain bar-
rier (BBB) tight junctions with subsequent formation of 
mild extracellular brain edema has been shown as the 
“normal” sequence of events under hypoxia [39]. Pre-
treatment enlarged insular GMV positively correlating 
with increased hypoxic severity partially supports this 
hypothesis.
In the present study, elevated systemic leukocyte apop-
tosis before treatment in OSA may result from BBB 
breakdown, elevated peripheral mediators, and inflam-
mation [40, 41]. In contrast, anti-inflammatory effects 
Table 4 Correlation between regional GMV and clinical disease severity (PSG parameters and leukocyte apoptosis)
Anatomical regions: Hipp/PCG/Precuneus, hippocampus/posterior cingulate gyrus/precuneus; STG/IFG/Insula, superior temporal gyrus/inferior frontal gyrus/insula
AHI apnea-hypopnea index; GMV gray matter volume; OSA obstructive sleep apnea; PSG polysomnography
* Statistical threshold was set at p < 0.05
Regional GMV differences between OSAbaseline and controls












r −0.337 0.140 −0.217 −0.181 −0.259 −0.282
p 0.059 0.444 0.234 0.321 0.153 0.117
Right Insula r 0.516 −0.574 0.508 0.419 0.364 0.405
p 0.003* 0.001* 0.003* 0.017* 0.041* 0.022*
Regional GMV differences between OSAbaseline and OSAfollow












r −0.035 −0.141 0.116 0.521 0.407 0.562
p 0.885 0.565 0.637 0.022* 0.084 0.012*
Left STG/IFG/Insula r 0.231 0.106 0.096 0.058 −0.199 −0.075
p 0.341 0.665 0.696 0.812 0.415 0.760
Left cerebellum r 0.201 0.311 0.167 −0.376 −0.438 −0.442
p 0.410 0.195 0.495 0.113 0.060 0.058
Fig. 3 Correlations between interval change of leukocyte profile and regional gray matter volume
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from interleukin, heat shock proteins, and adrenomedul-
lin can improve BBB function [42]. We found that 
decreased granulocyte and total leukocyte early apop-
tosis were associated with GMV reduction in the Hipp/
PCG/Precuneus. Furthermore, correction of increased 
GMV by reducing hypoxic exposure with surgery may 
re-normalize cerebral autoregulation and reduce subse-
quent leukocyte reaction. The results here support the 
possibility that cytokine-mediated BBB damage in cardi-
ovascular complications of OSA may partially contribute 
to alterations in GMV.
The present study has its limitations. Although there 
is improvement of cognitive functions after surgery, the 
report fails to demonstrate the relationship between 
them and systemic inflammation and GMV alteration, 
presumably because of the small sample size of OSA 
subjects. Furthermore, statistically significant associa-
tions, especially in small groups, do not necessarily mean 
a causal relationship. Partially corrected hypoxic status 
(AHI score, Pre-OP 38.77 vs. Post-OP 25.21) and non-
recovered brain injury (persistently decrease GMV in the 
anterior cingulate gyrus) after surgery may also explain 
the lesser improvement in neuropsychiatric functions. 
It is still too early to conclude on the long-term effects 
on brain structure, cognitive functions, and systemic 
inflammation from different treatments in OSA. Another 
limitation is that the healthy control subjects were not 
re-evaluated at 3  months, although changes in the GM 
of healthy participants over a short duration should be 
limited.
Conclusions
OSA can alter GM integrity in vulnerable regions, an 
effect associated with increased disease severity and sys-
temic inflammation. The possible interactions between 
systemic inflammation and GM changes may represent 
variant hypoxic patterns and their consequent processes. 
Surgical treatment can partially reverse structural brain 
abnormalities with reduced systemic inflammation. 
This study may serve as a motivator for better treatment 
adherence by patients.
Abbreviations
OSA: obstructive sleep apnea; GMV: gray matter volume; AHI: apnea‑hypo‑
pnea index; CPAP: continuous positive airway pressure; VBM: voxel‑based 
morphometry; GMV: gray matter volume; BMI: body mass index; MRI: mag‑
netic resonance imaging; CASI: cognitive ability screening instrument; WAIS‑III: 
Wechsler Adult Intelligence Scale; BDI: Beck Depression Inventory II; ANCOVA: 
analysis of covariance.
Additional file
Additional file 1. The procedure for the cross‑sectional voxel‑based 
morphometry pipeline.
Authors’ contributions
WCL participated in the project conception, organization, execution, statistical 
analysis, manuscript writing, review, and critique. CCH, PCC and MHC partici‑
pated in the execution of statistical analysis. HLC participated in the project 
execution and statistical analysis review. KHC participated in the statistical 
analysis, including design, execution, manuscript writing, review, and critique.  
NWT participated in the project organization and execution.  MF and HCL  
participated in the execution.  CHL participated in the project conception, 
organization, execution, statistical analysis, manuscript writing, review, and 
critique. All authors read and approved the final manuscript.
Author details
1 Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial 
Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan. 
2 Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, 
Chang Gung University College of Medicine, Kaohsiung, Taiwan. 3 Department 
of Biomedical Imaging and Radiological Sciences, National Yang‑Ming Univer‑
sity, Taipei, Taiwan. 4 Department of Brain Research Center, National Yang‑Ming 
University, Taipei, Taiwan. 5 Division of Sleep Surgery, Department of Otolar‑
yngology‑Head and Neck Surgery, Rush University Medical Center, Chicago, 
IL, USA. 6 Department of Otolaryngology, Advanced Center for Specialty Care, 
Advocate Illinois Masonic Medical Center, Chicago, IL, USA. 7 Department 
of Otolaryngology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung 
University College of Medicine, 123, Ta Pei Road, Niao Sung District, Kaohsiung, 
Taiwan. 8 Sleep Center, Kaohsiung Chang Gung Memorial Hospital, Chang 
Gung University College of Medicine, Kaohsiung, Taiwan. 9 Department of Bio‑
logical Science, National Sun Yat‑Sen University, Kaohsiung, Taiwan. 
Acknowledgements
This work was supported by grants from the National Science Council of the 
Republic of China (NSC NMRPG 8B6142 to HL Chen, and NMRPG8E6051 and 
NMRPG8E6052 to CH Lu) and Chang Gung Medical Research Project (CMRPG 
8C0021 to PC Chen). The authors wish to thank the MRI Core Facility of CGMH, 
as well as Yi‑Wen Chen and Ting‑Yi Chen, and all subjects who participated in 
this study.
Competing interests
The authors declare that they have no competing interests.
Received: 14 November 2015   Accepted: 28 April 2016
References
 1. Lavie L, Polotsky V. Cardiovascular aspects in obstructive sleep apnea 
syndrome—molecular issues, hypoxia and cytokine profiles. Respiration. 
2009;78:361–70.
 2. Aloia MS, Arnedt JT, Davis JD, Riggs RL, Byrd D. Neuropsychological 
sequelae of obstructive sleep apnea‑hypopnea syndrome: a critical 
review. J Int Neuropsychol Soc. 2004;10:772–85.
 3. Lavie L, Dyugovskaya L, Polyakov A. Biology of peripheral blood cells in 
obstructive sleep apnea–the tip of the iceberg. Arch Physiol Biochem. 
2008;114:244–54.
 4. Carson MJ, Thrash JC, Walter B. The cellular response in neuroinflamma‑
tion: the role of leukocytes, microglia and astrocytes in neuronal death 
and survival. Clin Neurosci Res. 2006;6:237–45.
 5. Lee SJ, Benveniste EN. Adhesion molecule expression and regulation on 
cells of the central nervous system. J Neuroimmunol. 1999;98:77–88.
 6. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B. Elevated C‑reactive protein 
levels and increased cardiovascular risk in patients with obstructive sleep 
apnea syndrome. Int Heart J. 2005;46:801–9.
 7. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, Luo C, Kheirandish L, Gozal D, Liu R. 
Increased oxidative stress is associated with chronic intermittent hypoxia‑
mediated brain cortical neuronal cell apoptosis in a mouse model of 
sleep apnea. Neuroscience. 2004;126:313–23.
 8. Weng HH, Tsai YH, Chen CF, Lin YC, Yang CT, Tsai YH, Yang CY. Mapping 
gray matter reductions in obstructive sleep apnea: an activation likeli‑
hood estimation meta‑analysis. Sleep. 2014;37:167–75.
Page 11 of 11Lin et al. J Transl Med  (2016) 14:139 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 9. Canessa N, Castronovo V, Cappa SF, Aloia MS, Marelli S, Falini A, Alemanno 
F, Ferini‑Strambi L. Obstructive sleep apnea: brain structural changes and 
neurocognitive function before and after treatment. Am J Respir Crit Care 
Med. 2011;183:1419–26.
 10. Huynh NT, Prilipko O, Kushida CA, Guilleminault C. Volumetric brain mor‑
phometry changes in patients with obstructive sleep apnea syndrome: 
effects of CPAP treatment and literature review. Front Neurol. 2014;5:58.
 11. Kim H, Joo E, Suh S, Kim JH, Kim ST, Hong SB. Effects of long‑term 
treatment on brain volume in patients with obstructive sleep apnea 
syndrome. Hum Brain Mapp. 2016;37:395–409.
 12. Haniffa M, Lasserson TJ, Smith I: Interventions to improve compliance 
with continuous positive airway pressure for obstructive sleep apnoea. 
Cochrane Database Syst Rev 2004:CD003531.
 13. Lin HS, Zuliani G, Amjad EH, Prasad AS, Badr MS, Pan CJ, Rowley JA. Treat‑
ment compliance in patients lost to follow‑up after polysomnography. 
Otolaryngol Head Neck Surg. 2007;136:236–40.
 14. Chen HL, Lu CH, Lin HC, Chen PC, Chou KH, Lin WM, Tsai NW, Su YJ, Fried‑
man M, Lin CP, Lin WC. White matter damage and systemic inflammation 
in obstructive sleep apnea. Sleep. 2015;38:361–70.
 15. Sleep‑related breathing disorders in adults: recommendations for 
syndrome definition and measurement techniques in clinical research. 
The Report of an American Academy of Sleep Medicine Task Force. Sleep 
1999, 22:667–689
 16. Huang CC, Lin WC, Chen HL, Friedman M, Lin MC, Lin HC, Lu CH. Improve‑
ment of baroreflex sensitivity in patients with obstructive sleep apnea 
following surgical treatment. Clin Neurophysiol. 2016;127:544–50.
 17. Lin HC, Friedman M, Chang HW, Gurpinar B. The efficacy of multilevel 
surgery of the upper airway in adults with obstructive sleep apnea/hypo‑
pnea syndrome. Laryngoscope. 2008;118:902–8.
 18. Lin HC, Friedman M, Chang HW, Su MC, Wilson M. Z‑palatopharyn‑
goplasty plus radiofrequency tongue base reduction for moderate/
severe obstructive sleep apnea/hypopnea syndrome. Acta Otolaryngol. 
2010;130:1070–6.
 19. Lin HC, Friedman M, Chang HW, Yalamanchali S. Z‑palatopharyngoplasty 
combined with endoscopic coblator open tongue base resection for 
severe obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head 
Neck Surg. 2014;150:1078–85.
 20. Lin WC, Tsai NW, Huang YC, Cheng KY, Chen HL, Li SH, Kung CT, Su YJ, 
Lin WM, Chen MH, et al. Peripheral leukocyte apoptosis in patients with 
Parkinsonism: correlation with clinical characteristics and neuroimaging 
findings. Biomed Res Int. 2014;2014:635923.
 21. Lin WC, Chen PC, Wang HC, Tsai NW, Chou KH, Chen HL, Su YJ, Lin CP, Li 
SH, Chang WN, Lu CH. Diffusion tensor imaging study of white matter 
damage in chronic meningitis. PLoS One. 2014;9:e98210.
 22. Lin WC, Chou KH, Chen CL, Chen HL, Lu CH, Li SH, Huang CC, Lin CP, 
Cheng YF. Longitudinal brain white matter alterations in minimal hepatic 
encephalopathy before and after liver transplantation. PLoS One. 
2014;9:e105887.
 23. Teng EL, Hasegawa K, Homma A, Imai Y, Larson E, Graves A, Sugimoto 
K, Yamaguchi T, Sasaki H, Chiu D, et al. The Cognitive Abilities Screening 
Instrument (CASI): a practical test for cross‑cultural epidemiological stud‑
ies of dementia. Int Psychogeriatr. 1994;6(45–58):discussion 62.
 24. Hsin‑Yi Chen M‑SH, Jianjun Zhu, Yung‑Hwa Chen. Selection of Factor‑
Based WAIS‑III Tetrads in the Taiwan Standardization Sample: a guide to 
clinical practice. Chinese Journal of Psychology. 2008;50:91–109.
 25. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of beck depression inven‑
tories ‑IA and ‑II in psychiatric outpatients. J Pers Assess. 1996;67:588–97.
 26. Chou KH, Lin WC, Lee PL, Tsai NW, Huang YC, Chen HL, Cheng KY, Chen 
PC, Wang HC, Lin TK, et al. Structural covariance networks of striatum 
subdivision in patients with Parkinson’s disease. Hum Brain Mapp. 
2015;36:1567–84.
 27. Yang FC, Chou KH, Fuh JL, Huang CC, Lirng JF, Lin YY, Lin CP, Wang SJ. 
Altered gray matter volume in the frontal pain modulation network in 
patients with cluster headache. Pain. 2013;154:801–7.
 28. Jelic S, Le Jemtel TH. Inflammation, oxidative stress, and the vascular 
endothelium in obstructive sleep apnea. Trends Cardiovasc Med. 
2008;18:253–60.
 29. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger 
W, Grimminger F. Enhanced release of superoxide from polymorphonu‑
clear neutrophils in obstructive sleep apnea. Impact of continuous posi‑
tive airway pressure therapy. Am J Respir Crit Care Med. 2000;162:566–70.
 30. Baessler A, Nadeem R, Harvey M, Madbouly E, Younus A, Sajid H, Naseem 
J, Asif A, Bawaadam H. Treatment for sleep apnea by continuous positive 
airway pressure improves levels of inflammatory markers—a meta‑analy‑
sis. J Inflamm (Lond). 2013;10:13.
 31. Kabara E, Coussens PM. Infection of primary bovine macrophages with 
mycobacterium avium subspecies paratuberculosis suppresses host cell 
apoptosis. Front Microbiol. 2012;3:215.
 32. Dhar‑Mascareno M, Carcamo JM, Golde DW. Hypoxia‑reoxygenation‑
induced mitochondrial damage and apoptosis in human endothelial 
cells are inhibited by vitamin C. Free Radic Biol Med. 2005;38:1311–22.
 33. Joo EY, Tae WS, Lee MJ, Kang JW, Park HS, Lee JY, Suh M, Hong SB. 
Reduced brain gray matter concentration in patients with obstructive 
sleep apnea syndrome. Sleep. 2010;33:235–41.
 34. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, Woo MA, 
Harper RK, Yan‑Go FL, Harper RM. Brain morphology associated with 
obstructive sleep apnea. Am J Respir Crit Care Med. 2002;166:1382–7.
 35. Morrell MJ, McRobbie DW, Quest RA, Cummin AR, Ghiassi R, Corfield DR. 
Changes in brain morphology associated with obstructive sleep apnea. 
Sleep Med. 2003;4:451–4.
 36. O’Donoghue FJ, Briellmann RS, Rochford PD, Abbott DF, Pell GS, Chan CH, 
Tarquinio N, Jackson GD, Pierce RJ. Cerebral structural changes in severe 
obstructive sleep apnea. Am J Respir Crit Care Med. 2005;171:1185–90.
 37. Mairer K, Gobel M, Defrancesco M, Wille M, Messner H, Loizides A, 
Schocke M, Burtscher M. MRI evidence: acute mountain sickness is 
not associated with cerebral edema formation during simulated high 
altitude. PLoS One. 2012;7:e50334.
 38. Mairer K, Wille M, Burtscher M. The prevalence of and risk factors for acute 
mountain sickness in the Eastern and Western Alps. High Alt Med Biol. 
2010;11:343–8.
 39. Bailey DM, Bartsch P, Knauth M, Baumgartner RW. Emerging concepts 
in acute mountain sickness and high‑altitude cerebral edema: from the 
molecular to the morphological. Cell Mol Life Sci. 2009;66:3583–94.
 40. Bailey DM, Evans KA, James PE, McEneny J, Young IS, Fall L, Gutowski 
M, Kewley E, McCord JM, Moller K, Ainslie PN. Altered free radical 
metabolism in acute mountain sickness: implications for dynamic 
cerebral autoregulation and blood‑brain barrier function. J Physiol. 
2009;587:73–85.
 41. Subudhi AW, Panerai RB, Roach RC. Effects of hypobaric hypoxia on 
cerebral autoregulation. Stroke. 2010;41:641–6.
 42. Julian CG, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC. Acute 
mountain sickness, inflammation, and permeability: new insights from a 
blood biomarker study. J Appl Physiol. 1985;2011(111):392–9.
